Traws Pharma to Report Second Quarter 2025 Financial Results on Thursday, August 14, 2025
NEWTOWN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Traws Pharma, Inc. (NASDAQ: TRAW) (“Traws Pharma”, “Traws” or “the Company”), a clinical-stage biopharmaceutical company developing novel therapies...
What is the outlook for the company's operating expenses and R&D spend in the upcoming quarters, and how might that influence profitability trends?
Are there any upcoming catalysts (e.g., data readouts, FDA meetings) that could drive the stock price in the near term?
What was the market reaction to the earnings release and conference call, and are there any immediate price implications for the stock?
23 days ago